Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
New ESC 24 Guidelines for AF
Author(s): Isabelle C Van Gelder Added: 1 year ago
ESC Congress 2024 — Chair, Prof Isabelle C Van Gelder (University of Groningen, NL) joins us to discuss key highlights from the ESC Atrial Fibrillation 2024 guidelines.The new guidelines centre on shared and equal care, patient empowerment, comorbidities and risk factor management, and evidence-based management and re-evaluation. The new AF-CARE pathway integrates comorbidity management,… View more

Electrophysiology & Arrhythmia
AHA 25: HFpEF as an Adipose Tissue Disorder
Author(s): Milton Packer Added: 1 month ago
AHA Scientific Sessions 2025 - Dr Milton Packer (Baylor University Medical Center, US) joins us to discuss his novel unifying hypothesis that heart failure with preserved ejection fraction arises primarily from visceral adipose tissue dysfunction and altered adipokine signaling, rather than as a heterogeneous disorder driven by multiple comorbidities.Interview Questions:Can you explain the core… View more

Cardiovascular Renal Metabolic

Heart Failure
AHA 25 Late-breaking Discussion: The BETTER-BP Trial
Author(s): John Dodson , Harriette Van Spall Added: 1 month ago
AHA Scientific Sessions 2025 — Late-breaker host Dr Harriette Van Spall (McMaster University, Hamilton, CA) is joined by BETTER-BP Principal Investigator Dr John Dodson (NYU Langone Health, New York, US) to present the findings of this AHA late-breaking trial (NCT04114669).The BETTER-BP (Behavioral Economics Trial to Enhance Regulation of Blood Pressure) is a phase II pragmatic randomized… View more

Prevention & Chronic Conditions
Michael Fu
Job title: Professor, Principal Investigator, Senior Consultant Physician/Cardiologist
Professor Michael Fu is currently a nucleus member of working group of heart failure with preserved ejection fraction, Heart Failure Association, European Society of Cardiology, and an nucleus member of the National Working Group of Heart Failure in Sweden. Michael Fu is an expert in heart failure with research focus on epidemiology, clinical phenotype, prognosis and its risk factors,… View more
Lars Kober
Dr Lars Kober is a professor of Cardiology and consultant from University of Copenhagen. Dr Kober serves as a member of the executive committee or steering committee in a number of large trials in heart failure and ischemic heart disease. The publication list encompasses more than 700 peer reviewed papers, and includes the 2015, 2016, 2017 Highly Cited Researchers listing by Thomson Reuters. Dr… View more
Prof Nikolaus Marx
Research Area(s) / Expertise: Job title: Professor of Medicine
Prof Dr Marx is a distinguished Professor of Medicine and Cardiology at the RWTH University Hospital Aachen, Germany. His clinical and research interests are centrally focused on cardiovascular disease in patients presenting with significant comorbidities, including Type 2 diabetes mellitus and chronic kidney disease. Prof Marx is a recognised authority on the interplay between metabolic… View more
Research Area(s) / Expertise: Job title: Professor of Medicine
Dr Eileen O’Meara is Professor at the Department of Medicine at the University of Montrealand practices cardiology at the Montreal Heart Institute. Dr O’Meara pursued a Fellowship in Heart Failure at the Western Infirmary & Glasgow Royal Infirmary in the UK, and another in Stress Echocardiography and Tissue Doppler at Hôpital Européen Georges Pompidou in Paris. Her research focuses on… View more
Building Excellence in Heart Team Collaboration with Dr Carla Agatiello
Author(s): Carla Agiatiello Added: 4 months ago
Discover the essential elements of effective multidisciplinary heart team collaboration in transcatheter and surgical aortic valve replacement with Dr Carla Agiatiello (Hospital Italiano, Buenos Aires, Argentina).This presentation, part of the Structural Interventions track, explores the critical role of comprehensive team-based decision-making in optimizing patient outcomes for aortic valve… View more

Demographic

Intervention
PERFORMANCE II: Two-Year Outcomes
Author(s): William Gray Added: 7 months ago
Safety and effectiveness outcomes of a 3-in-1 carotid stent delivery system show no major strokes at 30-day and one-year follow ups and significantly low rates of clinically driven target lesion revascularisation at two years.Dr William Gray (Main Line Health, Pennsylvania, US) joins us to discuss the first European presentation of the two-year outcomes from PERFORMANCE II (NCT04201132; Contego… View more

Vascular Disease and Surgery
EHRA 24: A Substudy of NOAH-AFNET 6
Author(s): Julius Nikorowitsch Added: 1 year ago
EHRA 24 - We are joined onsite by Dr Julius Nikorowitsch (University Heart and Vascular Centre Hamburg (UHZ), DE) to outline the impact of age, sex, cardiovascular comorbidities, and kidney function on outcomes with oral anticoagulation therapy in patients with device-detected atrial fibrillation in a substudy of the NOAH-AFNET 6 trial (NCT02618577).The substudy consisted of 2534 patients from… View more

Electrophysiology & Arrhythmia